Pay in 4 interest-free payments of $5.37 Learn more
Ships within 48 hours · Estimated delivery Nov 4 - Nov 9
But they target different receptors, and that distinction drives the meaningful difference in their efficacy profiles
Even if cost or side effects are driving the decision to quit, there may be options you haven't considered, including a different formulation
Journal of Neuroscience , 31 (17), 6587-6594
Clinical Pharmacology & Therapeutics, 102 (3), 436449
Based on Phase 2 trial data, retatrutide's side effect profile appears broadly consistent with other incretin-based therapies, though the addition of glucagon receptor agonism introduces some distinct considerations
US$ 23.69
US$ 28.48
US$ 29.82
US$ 22.51
US$ 29.87
US$ 22.33
US$ 21.98
US$ 26.03
US$ 23.18
US$ 24.04
